Suibiovac Ery Inaktywowane bakterie:-Erysipelothrix rhusiopathiae szczep OV1 (serotyp 1) R.P* ≥ 1-Erysipelothrix rhusiopathiae szczep OV2 (serotyp 2) R.P* ≥ 1(*) względna moc oznaczona metodą in-vitro w porównaniu do szczepionki referencyjnej zgodnie zFarmakopeą Europejską. Zawiesina do wstrzykiwań
Suibiovac Ery Inaktywowane bakterie:-Erysipelothrix rhusiopathiae szczep OV1 (serotyp 1) R.P* ≥ 1-Erysipelothrix rhusiopathiae szczep OV2 (serotyp 2) R.P* ≥ 1(*) względna moc oznaczona metodą in-vitro w porównaniu do szczepionki referencyjnej zgodnie zFarmakopeą Europejską. Zawiesina do wstrzykiwań
Authorised
- Erysipelothrix rhusiopathiae, serotype 1, strain OV1, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain OV2, Inactivated
Product identification
Medicine name:
Suibiovac Ery Inaktywowane bakterie:-Erysipelothrix rhusiopathiae szczep OV1 (serotyp 1) R.P* ≥ 1-Erysipelothrix rhusiopathiae szczep OV2 (serotyp 2) R.P* ≥ 1(*) względna moc oznaczona metodą in-vitro w porównaniu do szczepionki referencyjnej zgodnie zFarmakopeą Europejską. Zawiesina do wstrzykiwań
Active substance:
- Erysipelothrix rhusiopathiae, serotype 1, strain OV1, Inactivated
- Erysipelothrix rhusiopathiae, serotype 2, strain OV2, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 1, strain OV1, Inactivated1.00/relative potency2.00millilitre(s)
-
Erysipelothrix rhusiopathiae, serotype 2, strain OV2, Inactivated1.00/relative potency2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Drwalewskie Zaklady Przemyslu Bioweterynaryjnego S.A.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2077
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 4/02/2022